Mark Gustafson, chief executive of (), discusses the company’s new appointments and upcoming opportunities for the investment firm in giant observation wheel projects.
Financier Richard Marin, who helped raise US$500mln for the New York Wheel, has joined the board, with John Le Poidevin coming on board as chairman.
Gustafson, who has swapped the role of chairman for chief executive, says the company sees lots of potential project opportunities across Europe, South East Asia, the US and the Middle East.
Meet Advanced Oncotherapy, VolitionRx, Scancell Holdings Plc, Faron Pharmaceuticals Oy and Highlands Natural Resources Plc at our event,
London, 26 January 2017.
Register here »